Ozempic Price in 2026: List Cost, Coupons, and Savings

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub, your resource on GLP-1 therapy, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

The price attached to Ozempic is one of the first things people research before starting semaglutide. The number on the shelf and the number you pay are rarely the same, because insurance, savings programs, and compounded options all pull in different directions. This article lays out the published list price, the savings landscape, and the compounding context as of April 2026, reported as published rather than guaranteed.

The sticker price on Ozempic

Ozempic list price is approximately $968 to $1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). Think of that as the sticker price: the figure before insurance, rebates, savings cards, and pharmacy negotiation come into play. It is rarely what an insured patient pays at the counter, but it is the anchor every discount is measured against. Keeping that distinction in mind makes the quoted numbers you see online easier to interpret, since most reflect a specific coverage situation rather than a universal price.

Why insured patients rarely pay the list number

Coverage for Ozempic depends on whether the prescription is written for an FDA-approved indication and on the plan's formulary. Many commercial plans cover semaglutide for type 2 diabetes, while coverage for chronic weight management is more variable and frequently subject to prior authorization or BMI-based criteria. Because plan rules differ, the same list price can translate into wildly different out-of-pocket totals. Check directly with your plan as of April 2026.

Savings cards and pharmacy discount platforms

Novo Nordisk publishes a manufacturer savings card that can substantially reduce monthly out-of-pocket cost for eligible commercially-insured patients. Independent pharmacy discount platforms such as GoodRx and SingleCare also publish coupon prices that vary by pharmacy. Eligibility rules and savings amounts change over time, so verify current terms on the manufacturer website or with your pharmacy at the time of fill.

Compounded semaglutide and the shortage timeline

Between 2022 and 2024 the FDA listed semaglutide on its drug shortage list, opening a pathway for licensed 503A compounding pharmacies to compound semaglutide formulations. The FDA resolved the semaglutide shortage in 2024, narrowing but not eliminating that pathway. Legitimate compounded protocols, prescribed by a licensed clinician through a state-licensed compounding pharmacy, remain a real option, priced separately from the brand and varying widely in access.

How PlexusDx prices its GLP-1 protocols

PlexusDx offers clinician-supervised compounded GLP-1 protocols inside its Weight Management Protocols, including Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, Tirzepatide Oral, Microdose GLP-1, and GLP-Squared. See the relevant product page for current pricing as of April 2026.

Upstream of any protocol decision, the PlexusDx Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, GLP1R, and MC4R that shape baseline GLP-1, appetite-regulation, and energy-balance biology. That genetic context is the test before you invest framing PlexusDx applies to every protocol conversation.

Related reading on PlexusDx: Ozempic Over the Counter, Ozempic Semaglutide, Ozempic for PCOS, Ozempic on Line.

Disclaimer: This article is educational. PlexusDx offers semaglutide through its Weight Management Protocols, and this article covers the mechanism, evidence, and genetic context that inform any decision to use it. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Learn more about the PlexusDx Semaglutide protocol or the oral semaglutide protocol inside the Weight Management Protocols collection. To start upstream with genetic context, take the Precision Peptide Genetic Test first.

Frequently Asked Questions

What is the current list price of Ozempic?

Ozempic list price is approximately $968 to $1,029 per month at U.S. list price as of April 2026 (Novo Nordisk published pricing). That is the sticker figure before insurance, rebates, and savings cards. Most insured patients pay considerably less, so confirm your actual price with the pharmacy at the time of fill.

Why is Ozempic priced so high?

Ozempic is a patent-protected branded medication, and Novo Nordisk sets list price around research cost recovery, market positioning, and expected payer mix. Prices have stayed high partly because demand outpaced manufacturing in 2023 and 2024. Savings programs and compounded alternatives are the main levers patients use to reduce spend.

Is compounded semaglutide priced lower than brand Ozempic?

Often yes. Compounded semaglutide from licensed 503A pharmacies has historically been priced below Ozempic list price. The trade-offs are regulatory complexity, variability in prescriber oversight, and the FDA's evolving stance after the 2024 shortage resolution. Discuss suitability with a qualified clinician before choosing this route.

How does the Precision Peptide Genetic Test relate to price decisions?

It neither predicts response nor sets a price. It analyzes pathway-level variants in FTO, GLP1R, and MC4R that shape baseline GLP-1 biology, adding upstream context so any decision about spending on a GLP-1 protocol begins from an informed conversation rather than a sticker price alone.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.